R. Bryan Bell, MD, DDS, FACS, FRCS(Ed) (@rbryanbell) 's Twitter Profile
R. Bryan Bell, MD, DDS, FACS, FRCS(Ed)

@rbryanbell

Cancer Institute Director. Head & Neck Surgeon. Clinical Researcher focused on #immunotherapy. Relentlessly working to #FinishCancer @Providence Tweets my own

ID: 4447438632

linkhttps://oregon.providence.org/our-services/p/providence-cancer-center/ calendar_today04-12-2015 00:56:17

3,3K Tweet

2,2K Takipçi

668 Takip Edilen

R. Bryan Bell, MD, DDS, FACS, FRCS(Ed) (@rbryanbell) 's Twitter Profile Photo

Delighted to present path response from our Neoadjuvant ImmunoRadioTherapy (NIRT-2) trial in pts w HPV- HNSCC ASCO mPR=71% pCR=29% Downstaging=67% Omission of adjuvant RT=83% Surgical de-escalation=50% Earle A. Chiles Research Institute UCSD Health Moores Cancer Center COE Joseph Califano UCSD Cancer #ASCO25 meetings.asco.org/abstracts-pres…

Delighted to present path response from our Neoadjuvant ImmunoRadioTherapy (NIRT-2) trial in pts w HPV- HNSCC <a href="/ASCO/">ASCO</a>
mPR=71%
pCR=29%
Downstaging=67%
Omission of adjuvant RT=83%
Surgical de-escalation=50%
<a href="/ChilesResearch/">Earle A. Chiles Research Institute</a> <a href="/UCSDCancer_COE/">UCSD Health Moores Cancer Center COE</a> <a href="/CalifanoMd/">Joseph Califano UCSD Cancer</a>
#ASCO25

meetings.asco.org/abstracts-pres…